ArticlePloS one2025
Residual XGBoost regression-Based individual moving range control chart for Gross Domestic Product growth monitoring.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and reliable Gross Domestic Product (GDP) forecasting is indispensable for informed economic policymaking and risk management. Autocorrelation, a prevalent characteristic of macroeconomic time series, poses significant challenges to traditional forecasting methodologies and statistical process control. This study introduces a novel approach to GDP forecasting and monitoring by integrating XGBoost regression, a robust machine learning algorithm, with Individual and Moving Range (I-MR) control charts. By effectively capturing complex nonlinear relationships and mitigating autocorrelation, the proposed model offers enhanced predictive accuracy compared to conventional methods. Empirical results demonstrate the model's efficacy in phase I, aligning closely with actual GDP values. However, phase II analysis reveals discrepancies, suggesting the need for further model refinement and the potential incorporation of additional economic indicators to improve forecast precision.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.